Why it's a bit surprising that the U.S. is attending a key global flu meeting

United States News News

Why it's a bit surprising that the U.S. is attending a key global flu meeting
United States Latest News,United States Headlines
  • 📰 KPBSnews
  • ⏱ Reading Time:
  • 239 sec. here
  • 5 min. at publisher
  • 📊 Quality Score:
  • News: 99%
  • Publisher: 63%

After the U.S. withdrew from the World Health Organization, it wasn't clear they would participate in this WHO-led meeting to determine the recipe for the next flu vaccine.

A shot for a flu vaccination. A late February meeting of scientists from around the world is figuring out the recipe for the best vaccine for the upcoming fall flu season. For the past week, about 50 flu scientists from around the world have been cramming into a conference room at a Hilton hotel in Istanbul, Turkey.

Their goal is to design a flu shot that will confer the best protection for the next flu season —starting in the fall of 2026. Each day, they pore over reams of data — about how the virus is evolving worldwide, how well last year's shot performed, and which strains might be easiest to mass produce for a vaccine. The meeting, convened by the World Health Organization twice a year, is a critical moment for the WHO's Global Influenza Surveillance and Response System., who led the Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases from 2023 to 2025."In order for you to make the best choice for what to put in the vaccine, you have to review a lot."from the WHO in January, it wasn't clear the U.S. would participate in any WHO-led meeting. Earlier this month, the administration confirmed CDC would be sending staff despite the U.S. exit from the organization, albeit virtually instead of in person. "CDC representatives will take part in the meeting to support international technical collaboration," the Department of Health and Human Services said in a statement to NPR."Their participation will solely focus on providing technical expertise, sharing surveillance data, and contributing to scientific discussions that inform vaccine strain recommendations. This participation does not change the U.S. position on withdrawing from the WHO.", director of the Pandemic Center at Brown University. The Trump administration"may bluster and say, 'We're not going to do this,' but at some point, they run into reality, which is that there is no other way to protect the nation." Still, the U.S. withdrawal from the WHO has challenged this global system and could ultimately diminish the influence of the U.S. in shaping the flu vaccine.Those samples are then sent to seven larger labs — including the CDC in the United States. They're referred to as WHO collaborating centers, and they try to make sense of all that virus data and select strains that might be suitable for vaccines. That global system depends on the constant flow of samples from many countries to those seven bigger labs. WHO foots the bill for the shipment of samples, but when its biggest funder — the U.S. — pulled out last year, the flow of influenza samples slowed down in large part because of the loss of U.S. dollars. Fewer samples means a dimmer view of influenza's evolution, which could make it harder to know which strains to put in next season's vaccine. "There was a slight dip in the circulation of influenza vaccines around the world because of a challenge with some funding," said, interim director of the department of epidemic and pandemic threat management at WHO, at a February 11 press conference."But we have been able to resume the shipments around the world." Still, Jernigan worries about the long-term viability of the system, given WHO's funding constraints. The recent uptick"does not mean things are back to normal," he says. Another departure from normality is the absence of U.S. officials literally at the conference room table. "You want the whole process to be very objective and quantitative, but ultimately the interaction of the different researchers is really important," says Jernigan. CDC researchers have always had a lot of sway in picking which strains to include in the vaccine. But with U.S. officials only participating virtually, and the U.S. shunning international collaboration more generally, representatives from other countries may be less inclined to follow America's lead. "You want your country's problems to be represented in what flu virus gets selected" to ensure the best match, says Jernigan. With the U.S. in virtual attendance only, he says,"there's really not an incentive for them to select the vaccine virus that represents what may be circulating in the United States." NPR asked the Department of Health and Human Services, which houses CDC, to address that concern but the agency did not provide a response. Friday morning, WHO will announce the strains recommended by the committee for next year's flu shot. Then manufacturers start the production process, which takes about nine months until the shots are ready to go., dean of public health at the University of Nebraska."It's reassuring at least that the CDC will be at these meetings," he says, but"participating or not, we're seeing a bleeding of influence of the U.S. government in global health."Jonathan Lambert is a correspondent for NPR's Science Desk, where he covers the wonders of the natural world and how policy decisions can affect them.KPBS keeps you informed with local stories you need to know about — with no paywall. Our news is free for everyone because people like you help fund it.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

KPBSnews /  🏆 240. in US

 

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Families and health professionals advocate for mental health help for kidsFamilies and health professionals advocate for mental health help for kidsAnusha Roy is the weekday morning anchor for Denver7. You can watch her weekdays at 4:30, 5 and 6 a.m.
Read more »

UN World Food Program head Cindy McCain says she will step down for health reasonsUN World Food Program head Cindy McCain says she will step down for health reasonsU.N. World Food Program Executive Director Cindy McCain has announced she will step down as the head of the humanitarian organization in three months to focus on her health.
Read more »

History shows us we do not need to medicalise problems to support people.History shows us we do not need to medicalise problems to support people.Why are sickness benefits for mental health problems rising?
Read more »

UN World Food Program head Cindy McCain says she will step down for health reasonsUN World Food Program head Cindy McCain says she will step down for health reasonsThe 71-year-old suffered a mild stroke in October 2025.
Read more »

U.N. World Food Program head Cindy McCain says she will step down for health reasonsU.N. World Food Program head Cindy McCain says she will step down for health reasonsThe 71-year-old American suffered a mild stroke in October 2025 and returned in early January to the WFP’s headquarters in Rome to resume her duties.
Read more »

UN World Food Program head Cindy McCain says she will step down for health reasonsUN World Food Program head Cindy McCain says she will step down for health reasonsSource of breaking news and analysis, insightful commentary and original reporting, curated and written specifically for the new generation of independent and conservative thinkers.
Read more »



Render Time: 2026-04-01 19:32:44